ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Pursuant to the Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Ltd has informed BSE that its Board of Directors will meet on Friday, 14 November 2025 at 5:00 PM at the registered office in Amritsar. The key agenda is to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter and half year ended 30 September 2025 (Q2 FY26 / H1 FY26). The trading window for insiders has been closed since 1 October 2025 and will reopen 48 hours after the results are made public on 14 November 2025.
This is a routine regulatory filing ahead of the Q2 FY26 earnings announcement. Shareholders should watch for the actual results on 14 November 2025 for any material updates on revenue, profitability, and outlook. No immediate impact on the stock from this intimation alone.